Maïa Chanrion
Servier (France)(FR)Institut des Hautes Études Scientifiques(FR)
Publications by Year
Research Areas
Cell death mechanisms and regulation, Cancer-related Molecular Pathways, Bioinformatics and Genomic Networks, Ubiquitin and proteasome pathways, Breast Cancer Treatment Studies
Most-Cited Works
- → The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models(2016)1,037 cited
- → Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening(2011)431 cited
- → CIP2A Is Associated with Human Breast Cancer Aggressivity(2009)225 cited
- → A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer(2008)201 cited
- → Synergistic action of the MCL-1 inhibitor S63845 with current therapies in preclinical models of triple-negative and HER2-amplified breast cancer(2017)191 cited
- → Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia(2018)172 cited
- → Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut(2014)132 cited
- → S55746 is a novel orally active BCL-2 selective and potent inhibitor that impairs hematological tumor growth(2018)109 cited
- → Discovery of S64315, a Potent and Selective Mcl-1 Inhibitor(2020)100 cited
- → The Transcriptional Coregulator RIP140 Represses E2F1 Activity and Discriminates Breast Cancer Subtypes(2010)59 cited